TO

Timothy Oldham

AdAlta Limited | Managing Director, Chief Executive Officer
Mr Oldham has 20 years of life sciences business development, alliance management and sales and marketing experience in Europe, Asia and Australia. He was previously CEO and Managing Director of Cell Therapies Pty Ltd and President of Asia Pacific for Hospira, Inc., having held a variety of senior management roles encompassing development and commercialisation of generic pharmaceuticals, devices, biologics and cellular therapies with Mayne Pharma Ltd prior to its acquisition by Hospira. He began his career as an engagement manager with McKinsey & Company. He is member of the Risk Committee and Chair of the Human Capital Committee.

Companies and Roles

Company
Title
Tenure
Since
1AD
1AD
AdAlta Limited
  • Managing Director
  • Chief Executive Officer
7yrsOct 2019
ACR
ACR
Acrux Limited
  • Non-Executive Director
13yrsOct 2013

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
ACR
ACR
Acrux Limited
03/09/26N/A7,598,307285,714N/A
1AD
1AD
AdAlta Limited
04/12/25017,265,41512,190,528N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
ACR
ACR
Acrux Limited
03/09/26
Issued
2,400,000$0.011$26,400Issue of securities
ACR
ACR
Acrux Limited
02/06/26
Buy
1,433,360$0.013$18,633Conversion of securities
ACR
ACR
Acrux Limited
02/06/26
Exercise
1,433,360$0.013$18,633Conversion of securities
1AD
1AD
AdAlta Limited
04/12/25
Exercise
1,396,999$0.003$4,889Conversion of securities
1AD
1AD
AdAlta Limited
04/12/25
Buy
1,396,999$0.003$4,889Conversion of securities